HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pei-Pei Kung Selected Research

PF-4942847

8/2011Effective targeting of triple-negative breast cancer cells by PF-4942847, a novel oral inhibitor of Hsp 90.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pei-Pei Kung Research Topics

Disease

8Neoplasms (Cancer)
11/2021 - 05/2007
2Triple Negative Breast Neoplasms
08/2014 - 08/2011
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2021
1Breast Neoplasms (Breast Cancer)
08/2014
1Chromosomal Instability (Chromosome Stability)
08/2014

Drug/Important Bio-Agent (IBA)

2Pharmaceutical PreparationsIBA
01/2018 - 09/2011
2CrizotinibIBA
09/2011 - 05/2007
2Biomarkers (Surrogate Marker)IBA
09/2011 - 08/2011
1ProdrugsIBA
11/2021
1PF-2771IBA
08/2014
1centromere protein EIBA
08/2014
1taxaneIBA
08/2014
1Histones (Histone)IBA
08/2014
1KinesinsIBA
08/2014
1Small Interfering RNA (siRNA)IBA
08/2014
1Phosphotransferases (Kinase)IBA
09/2011
1tyrosine receptor (receptor, tyrosine)IBA
09/2011
1Heat-Shock Proteins (Heat-Shock Protein)IBA
09/2011
1Protein Kinases (Protein Kinase)IBA
09/2011
1Proteins (Proteins, Gene)FDA Link
08/2011
1PF-4942847IBA
08/2011
1ErbB Receptors (EGF Receptor)IBA
08/2011
1Prostaglandins AIBA
12/2008
1Proto-Oncogene Proteins c-metIBA
05/2007
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
05/2007
1LigandsIBA
05/2007

Therapy/Procedure

2Therapeutics
08/2014 - 08/2011